Latest Good News on Evacetrapib

November 18th, 2011 by Ryan Luce No Comments

written by Michael O’Leary

If you have type 2 diabetes, you probably also battle cardiovascular disease often with statin drugs to lower your cholesterol. The American College of Physicians recommends that all people with diabetes and any other risk factor for cardiovascular disease should be taking cholesterol-lowering statin drugs.

Another promising new drug is undergoing testing that appears to boost good HDL cholesterol while lowering bad LDL cholesterol, and so far, without causing adverse effects on blood pressure that have stymied similar drugs. The latest clinical trial results of evacetrapib were highlighted in this week’s Journal of the American Medical Association.

Co-author Dr. Steven Nissen, of the Cleveland Clinic said these early results clear the way for larger studies. (Link to published site)

Does Actos Reduce Stroke Risk?

written by Michael O’Leary

Not to be outdone by upstart Juvisync, a new study shows that long-time type 2 diabetes drug, Actos, may also have blood vessel benefits.

The small study of 52 type 2 diabetes patients, published in the October Journal of the American College of Cardiology found that patients taking pioglitazone (Actos) had reduced inflammation associated with plaque deposits in the main arteries serving the head and neck. Such deposits are thought to increase the risk of stroke. (Link to published site)